•
Sep 30, 2021
Harrow Q3 2021 Earnings Report
Announced record revenues for the fifth consecutive quarter and reported record levels of other key financial and operational metrics.
Key Takeaways
Harrow Health reported a fifth consecutive quarter of strong top-line revenue growth for Q3 2021. The company also achieved record levels in other key financial and operational metrics.
Reported a fifth consecutive quarter of strong top-line revenue growth.
Achieved record revenue levels.
Reported record levels of other key financial and operational metrics such as revenue per shipping day and total number of product units dispensed.
Announced transactions to further Strategic Vision and drive growth, including the purchase of two drug candidates, AMP-100 and MAQ-100.